News Releases

Date Title

November 2016

Grassley Statement on President-elect Trump Selection of Senator Sessions for Attorney General
Administration Takes Steps to Implement Key Medication-assisted Treatment Provision in Grassley-Led Opioid Treatment Bill
Grassley Joins Bipartisan Effort Incentivizing Law Enforcement Agencies to Hire Veterans
Grassley Praises Final Passage of Veterans Crisis Line Improvement Bill
Concerns Remain with ChemChina’s Possible Use of U.S. Sovereign Immunity Laws
Grassley Seeks Inspector General Review of VA Dealings with Veteran Who Committed Suicide
Grassley Urges Defense Department Inspector General to Consider Stepping up the “War on Waste”
Grassley Probes DEA Payments to Confidential Sources Following Reports of Misconduct
Request Tickets to the 2017 Presidential Inauguration
Grassley Urges Justice Department to Testify Voluntarily at EpiPen Hearing
Honoring Veterans This Veterans Day
Grassley & 87 Congressional Colleagues Urge Court to Halt Obama Admin. Water Overreach
Grassley: Justice Department, CMS Should Testify at EpiPens Hearing
Inspector General Asked to Provide Records, Invited to Testify Over EpiPen Misclassification Identified in 2009
Judiciary Committee Leaders Seek FTC Review of EpiPen Maker for Potential Antitrust Violations
Bipartisan Bill Planned to Make Hearing Aids More Accessible and Affordable
Grassley, Colleagues Call on Mylan to Reimburse Defense Department for Excessive EpiPen Costs
Grassley: Vague Update on FBI’s Investigation of Clinton’s Emails Still Leaves Key Questions Unanswered
Grassley Outlines Reasons for Voting Against Omnibus Bill
Capitol Hill Report